3rd Quarter - Report

WALGREEN COMPANY for WALGREEN COMPANY

Firm
Client
Income
—
Expenses
$400,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to fraud, waste and abuse prevention in Medicare Part D; no legislation.

LobbyistCovered position, as disclosed
KATHARINE TROLLER BOND —
ALETHIA JACKSON —
EDWARD KALETA —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Pharmacy PHA

S. 314 and H.R. 592 - the "Pharmacy and Medically Underserved Areas Enhancement Act," all provisions related to amending the Social Security Act to allow pharmacists to be reimbursed under Medicare Part B for services provided to patients in medically underserved communities, consistent with state scope of practice laws.

LobbyistCovered position, as disclosed
KATHARINE TROLLER BOND —
ALETHIA JACKSON —
EDWARD KALETA —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: S. 314 (114th), H.R. 592 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.